We are live on ! Find out more
ABEOW

Abeona Therapeutics Inc Warrant

Delisted

ABEOW was delisted on the 20th of December, 2019.

5 hedge funds and large institutions have $7.49M invested in Abeona Therapeutics Inc Warrant in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

53% less capital invested

Capital invested by funds: $15.9M → $7.49M (-$8.36M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$5.57M
2
UBS Group
UBS Group
Switzerland
-$2.37K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$5.14M -$5.57M -600,000 -48%
HCM
2
Highbridge Capital Management
New York
$1.98M
OFG
3
OTA Financial Group
New York
$360K
UBS Group
4
UBS Group
Switzerland
$7K -$2.37K -255 -23%
Bank of America
5
Bank of America
North Carolina
$1K

ABEOW Hedge Fund Activity: Q3 2018 in Review

5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q3 2018, worth a combined $7.49M — down 53% from $15.9M a quarter earlier.

Fund positioning in ABEOW was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Perceptive Advisors, cutting an estimated $5.57M.

  • 5 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $7.49M of Abeona Therapeutics Inc Warrant stock for Q3 2018, down 53% quarter-over-quarter.
  • 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q3 2018 and 0 closed out.
  • The largest Abeona Therapeutics Inc Warrant seller in Q3 2018 was Perceptive Advisors, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2018.